Skip to Main Content
Imvax
  • About Us
    • Overview
    • Leadership Team
    • Board of Directors
    • Scientific Advisors
  • Our Science
    • Overview
    • Our GoldspireTM Platform
    • Advantages
    • Publications
  • Pipeline
    • Overview
    • Imvax Programs
      • IGV-001
      • IHC-001
      • IUC-001
      • ICC-001
      • IEC-001
      • IOC-001
    • Clinical Trials
  • News & Events
  • Culture & Careers
    • Our People
    • Benefits
    • Career Opportunities

Uhl, C., et al.

Uhl, C., et al. “Machine learning algorithm identifies key serum cytokines associated with evidence of clinical activity in patients treated with personalized immunotherapeutic platform (IGV-001).” Presented at AACR 2022.

601 Walnut Street, Suite 440W, Philadelphia, PA 19106
267-900-4110
contact@imvax.com

  • Careers at Imvax
  • Privacy Policy
  • Terms of Use
  • LinkedIn
  • Twitter
© Copyright 2023 Imvax®, Inc. All rights reserved.